Microfluidic Immunoassay Market to be Worth $1.47 Billion by 2030
Download Free sample report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5034
According to this latest publication from
Meticulous Research®, the global microfluidic immunoassay market is projected to
reach $1.47 billion by 2030 at a CAGR of 7.4%. The growth of this market is
driven by the increasing use of microfluidic immunoassays in drug discovery
& development and biomarker detection, the advantages of lab-on-chip
immunoassays over conventional immunoassays, pharmaceutical &
biotechnology companies' increasing focus on research & development, and
the miniaturization of biological and chemical assays. However, bubble
formation and dead volume in microfluidics devices restrain the growth of this
market.
Moreover, the increasing demand for
point-of-care diagnostics and recent advancements in microfluidic immunoassay
technology are expected to generate market growth opportunities. However, the
selection of suitable substrate materials for designing microfluidic chips and
product design and cost-related limitations in developing countries are major
challenges for market stakeholders.
Key Players
The key players operating in the global
microfluidic immunoassay market are Becton, Dickinson and Company (U.S.),
Revvity, Inc. (U.S.), Abbott Laboratories (U.S.), Siemens Healthineers AG
(Germany), Nanomix Corporation (U.S.), Micropoint Biotechnologies Co., Ltd.
(China), Biosurfit SA (Portugal), Koninklijke Philips N.V. (Netherland),
NanoEnTek Inc. (South Korea), and QuidelOrtho Corporation (U.S.)
Microfluidic Immunoassay
Market: Future Outlook
The global microfluidic immunoassay market is
segmented by Product (Consumables [Cartridges {Polymer, Glass, and Silicon}
and Reagents] and Systems), Technology (Electrochemical Detection and Optical
Detection), Application (Cardiology (Single Biomarker Detection and
Multiplexed Biomarker Detection), Infectious Diseases, Oncology, and Other
Applications), End User (Pharmaceutical & Biotechnology Companies,
Diagnostic Laboratories, Hospitals, and Other End Users), and Geography. The
study also evaluates industry competitors and analyzes their market share at
global and regional levels.
Among all products studied
in this report, the consumables segment is expected to grow at the highest
CAGR during the forecast period. The continuous advancements in the
development of reagents and kits, the adoption of microfluidic immunoassay
diagnostic kits for disease diagnosis, and ease of use are increasing the
demand for consumables used in the microfluidic immunoassay market, driving
its growth.
Speak to analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5034
Among all technologies
studied in this report, in 2023, the electrochemical detection
segment is expected to account for the largest share of the microfluidic
immunoassay market. The large market share of this segment is attributed to
factors such as the increasing adoption of electrochemical detection in
point-of-care testing, adaptability for miniaturization, rapid detection, and
low-cost methods.
Among all applications
studied in this report, the oncology segment is expected to
grow at the highest CAGR during the forecast period. The highest CAGR of this
segment is attributed to pharmaceutical & biotechnology research
organizations using microfluidic immunoassay for oncology biomarker detection
in research applications, such as anti-cancer drug studies, drug discoveries,
and personalized medicine.
Among all end users studied
in this report, in 2023, the pharmaceutical and biotechnology companies
segment is expected to account for the largest share of the microfluidic
immunoassay market. The largest share of this segment is attributed to the
increasing demand for new drugs and therapies, leading to extensive research
and development activities, rising funding and investments in the
pharmaceutical and biotech industry, and increasing healthcare expenditure.
Furthermore, the pharmaceutical and biotechnology industries constantly strive
to develop new drugs and therapies to address medical needs, further driving
market growth.
Geographic Review
This research report analyzes major
geographies and provides a comprehensive analysis of North America (U.S. and
Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe),
Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), Latin
America, and the Middle East & Africa.
Among all regions studied in
this report, Asia-Pacific is expected to grow at the highest CAGR during
the forecast period. The highest CAGR of the region is attributed to
advancements in healthcare infrastructure, development in the R&D sector,
increasing number of diagnostic laboratories in the region, and advancements
in the research sector in emerging economies of the region.
Quick Buy: https://www.meticulousresearch.com/Checkout/80588586
Key questions answered in
the report:
· Which are
the high-growth market segments in terms of product, technology, application,
end user, and regions/countries?
· What was
the historical market for microfluidic immunoassay across the globe?
· What are
the market forecasts and estimates for the period 2023–2030?
· What are
the major drivers, restraints, challenges, opportunities, and trends in the
global microfluidic immunoassay market?
· Who are
the major players in the global microfluidic immunoassay market?
· What is
the competitive landscape, and who are the market leaders in the global
microfluidic immunoassay market?
· What are
the recent developments in the microfluidic immunoassay market?
· What are
the different strategies adopted by the major players in the microfluidic
immunoassay market?
· What are
the geographical trends and high-growth regions/countries?
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment